Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure

Iron deficiency (ID) is one of the most common comorbidities in patients with heart failure (HF). ID is a strong independent predictor of outcomes in HF patients. ID reduces quality of life, exercise tolerance, and survival in patients with HF, regardless of anemia status. The latest 2021 gui...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	I. V. Zhirov, N. V. Safronova, S. N. Tereshchenko
Formatua:	Artikulua
Hizkuntza:	Russian
Argitaratua:	«FIRMA «SILICEA» LLC 2022-06-01
Saila:	Российский кардиологический журнал
Gaiak:	heart failure acute decompensated heart failure iron deficiency anemia ferric carboxymaltose
Sarrera elektronikoa:	https://russjcardiol.elpub.ru/jour/article/view/4940

Antzeko izenburuak

Intravenous iron therapy for heart failure and iron deficiency: An updated meta‐analysis of randomized clinical trials
nork: Mushood Ahmed, et al.
Argitaratua: (2025-02-01)

Prevalence and clinical significance of iron deficiency in patients with acute decompensated heart failure
nork: E. A. Smirnova, et al.
Argitaratua: (2023-09-01)

The Beneficial Effect of Intravenous Iron Administration for Chronic Heart Failure: An Updated Meta-analysis and Systematic Review
nork: Andrianto, et al.
Argitaratua: (2023-12-01)

Effect of intravenous iron supply in patients with heart failure with reduced ejection fraction – a literature review
nork: Katarzyna Dąbek, et al.
Argitaratua: (2024-12-01)

Iron substitution in the treatment of chronic heart failure
nork: Christine Gstrein, et al.
Argitaratua: (2017-06-01)

The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
nork: Inderbir Padda, et al.
Argitaratua: (2024-12-01)

Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
nork: Rachida Aouameur, et al.
Argitaratua: (2024-12-01)

Use and Effectiveness of Carboximaltose Iron in Preoperative Anemia Treatment: A Multicenter and Retrospective Study
nork: Yuste Gutierrez AM, et al.
Argitaratua: (2024-11-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
nork: M. V. Melnik, et al.
Argitaratua: (2015-12-01)

IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE
nork: N. I. Stuklov
Argitaratua: (2017-11-01)

Diagnostics of anemia and iron deficiency in patients with chronic heart failure
nork: O.O. Khanyukov, et al.
Argitaratua: (2023-03-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
nork: S. N. Tereshchenko, et al.
Argitaratua: (2011-04-01)

Treatment optimization for iron deficiency anemia in pregnant women as a resource to prevent perinatal complications
nork: T. P. Zefirova, et al.
Argitaratua: (2024-05-01)

The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
nork: Maria Ntoumpara, et al.
Argitaratua: (2024-11-01)

IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
nork: M. V. Lediakhova, et al.
Argitaratua: (2018-05-01)

Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
nork: N. A. Koziolova, et al.
Argitaratua: (2023-04-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
nork: I. A. Meray, et al.
Argitaratua: (2008-08-01)

Iron deficiency in new onset heart failure: association with clinical factors and quality of life
nork: Carin Corovic Cabrera, et al.
Argitaratua: (2024-10-01)

Postoperative Intravenous Iron Infusion in Anemic Colorectal Cancer Patients: An Observational Study
nork: Leonidas Chardalias, et al.
Argitaratua: (2024-09-01)

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
nork: A. G. Arutyunov
Argitaratua: (2013-04-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
nork: N. A. Koziolova, et al.
Argitaratua: (2020-05-01)

Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution
nork: S. A. Boytsov, et al.
Argitaratua: (2023-05-01)

Albuminuria as a marker of systemic congestion and a predictor of poor long-term prognosis in acute decompensated heart failure
nork: Zh. D. Kobalava, et al.
Argitaratua: (2024-05-01)

Problematic aspects of iron deficiency compensation in heart failure
nork: N. A. Makarova
Argitaratua: (2023-03-01)

The problem of anemia treatment in patients with chronic heart failure.
nork: V. P. Ivanov, et al.
Argitaratua: (2018-05-01)

Effect of ferric-carboxy maltose on oxygen kinetics and functional status in heart failure patients with iron deficiency
nork: Sandip Dhoot, et al.
Argitaratua: (2020-06-01)

DECOMPENSATED CHRONIC HEART FAILURE: FROM PATHOGENESIS TO PROGNOSIS
nork: K. S. Fazulina
Argitaratua: (2016-12-01)

Hypochloraemia and 30 day readmission rate in patients with acute decompensated heart failure
nork: Roman Marchenko, et al.
Argitaratua: (2020-06-01)

SGLT-2 inhibitors in the management of acute decompensated heart failure
nork: Anastasia E. Poskakalova, et al.
Argitaratua: (2024-11-01)

Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial
nork: Yu. M. Lopatin, et al.
Argitaratua: (2022-04-01)

Factors associated with iron deficiency in heart failure
nork: M. P. Smirnova, et al.
Argitaratua: (2023-03-01)

Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
nork: M. A. Efremovtseva, et al.
Argitaratua: (2008-08-01)

Decompensation of chronic heart failure after COVID-19: a clinical observation
nork: Marina V. Moiseeva, et al.
Argitaratua: (2023-02-01)

Clinical and biochemical features of some intravenous iron complexes
nork: S. Yu. Abashin, et al.
Argitaratua: (2014-07-01)

SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
nork: I. V. Zhirov, et al.
Argitaratua: (2015-09-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
nork: N. B. Lebedeva, et al.
Argitaratua: (2024-04-01)

Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation
nork: A. A. Gurkina, et al.
Argitaratua: (2023-02-01)

PATHOPHYSIOLOGY OF ACUTE HEART FAILURE. WHAT’S NEW?
nork: S. N. Tereshchenko, et al.
Argitaratua: (2016-09-01)

ASSOCIATION OF GALECTIN-3 WITH FACTORS OF DECOMPENSATION OF CHRONIC HEART FAILURE IN PATIENTS WITH OSTEOARTHRITIS
nork: A.S. Ankudinov
Argitaratua: (2022-12-01)

Targeting Inflammation and Iron Deficiency in Heart Failure: A Focus on Older Adults
nork: Daniela Maidana, et al.
Argitaratua: (2025-02-01)